News

Four innovators shortlisted for Health Tech World award

Published

on

Four health tech innovators have been shortlisted for the Most Improved Patient Outcomes Award, sponsored by NIHR Surgical Medtech Co-operative.

The four entries were among more than 130 submissions to the second annual Health Tech World awards.

A category winner will soon be decided by the award judge and announced at a virtual ceremony on April 18.

Most Improved Patient Outcomes Award 2024 shortlist:

Capri Healthcare’s TriVice has made a remarkable impact on improving patient outcomes in the NHS by transforming the way acute surgical referrals are managed.

This AI-powered triage system, developed in collaboration with Birmingham Women’s and Children’s NHS Foundation Trust, has streamlined clinical workflows, significantly enhancing clinician efficiency and patient care.

CitiusTech developed a single, enterprise-wide Population Management solution that enabled users to create customized cohorts across the client’s multiple care programmes, which led to a strong improvement in patient engagement.

CitiusTech achieved a significant reduction in readmission rates and ED visits, savings in manual efforts, and an increase in follow-up visits for one of its non-profit clients based out of the US.

Lightfully provides support to individuals facing mental health challenges at all levels of care by providing 24/7 residential care, PHP/IOP outpatient care, and virtual care options.

With Lightfully’s compassionate leadership and innovation, clients have shown: a 41 per cent decrease in depression scores, 45 per cent decrease in anxiety scores, and 32 per cent decrease in PTSD scores.

In addition, while nearly all clients admit to Lightfully with moderate-to-high suicide risk, only 9 per cent discharge at elevated risk.

Phagenyx is the first and only treatment using pharyngeal electrical stimulation (PES) to restore swallowing control, facilitate airway protection, and accelerate recovery.​

Phagenesis was nominated by Mid and South Essex NHS Foundation Trust, which has worked with the company over the past 12 months.

A spokesperson for the trust called the treatment a ‘game-changer’ for patients with sensory dysphagia.

Click to comment

Trending stories

Exit mobile version